« Back to Malignant Tumors of the Skin

Malignant Melanoma

»What is melanoma?
»How common is malignant melanoma in the United States?
»What causes melanoma?
»What groups have a genetic predisposition to familial melanoma?
»List the risk factors for melanoma.
»List the high-risk groups for developing melanoma.
»Do all melanomas develop from atypical nevi?
»What are cancer stem cells?
»Is melanoma a single disease?
»What are the molecular pathways in melanoma?
»Is there a host immune response to melanoma?
»Describe the clinical appearance of melanoma.
»What are the ABCDEs of melanoma?
»What is dermoscopy?
»Where on the body does melanoma most commonly arise?
»Are there different types of melanoma?
»What are Clark’s levels?
»What is Breslow’s depth?
»What other findings should be reported in the histopathologic diagnosis of melanoma?
»What are the common immunohistochemical (IHC) markers utilized in the diagnosis of melanoma?
»Are there other factors with prognostic impact in patients with melanoma?
»How are patients with melanoma evaluated after the initial diagnosis?
»What is the most current system for staging melanoma?
»How is melanoma treated?
»How wide should surgical margins be?
»What is the most important risk factor for local recurrence of primary melanoma?
»Does a biopsy of melanoma increase the risk of spreading tumor cells or causing metastases?
»Describe the recommended follow-up for a patient with melanoma.
»Which tests or examinations are conducted during the routine follow-up of patients who have had melanoma?
»Does local tumor recurrence influence overall survival?
»What is elective lymph node dissection (ELND)? When is it indicated?
»What is sentinel lymph node biopsy? When is it indicated?
»What is linear melanonychia?
»What is Hutchinson’s sign?
»What is Hutchinson’s freckle?
»Are there any new ways to assess prognosis in patients with melanoma?
»What forms of chemotherapy are used in the treatment of metastatic melanoma?
»Is radiation therapy effective for melanoma?
»How effective is immunotherapy in malignant melanoma?
»Does gene therapy offer any better results?
»How about local perfusion?
»What are some newer targeted therapies for melanoma?

 
 
 

Do all melanomas develop from atypical nevi?

In the past, the development of melanoma has been modeled as a stepwise process from a cutaneous melanocyte through nevus through atypical nevus stages to melanoma in situ and eventually invasive melanoma. However, around 40% to 75% of melanomas develop in normal skin de novo, and, of those melanomas that develop in association with a preexisting nevus, <50% of the nevi are atypical. At present it is difficult to determine whether an atypical nevus is any more likely to become a melanoma than any other nevus or isolated melanocyte. Moreover, it is now clear that a preexisting nevus is not required for a melanoma to develop. It is thought that the discrepancy between melanomas arising in preexisting nevi and de novo melanomas can best be explained by the cancer stem cell theory. In this regard, the risk of melanoma associated with nevi may be due to the potential for secondary mutations within nevi, as well as due to the inherent properties of the stem cell population in individuals with numerous moles. Therefore, although there is a clear association between nevi and melanoma risk, only a portion of this risk may be related to the acquisition of genetic mutations within the nevi. The majority of the risk may be associated with the inherent properties of melanocyte stem cell populations in individuals with numerous nevi.

Friedman RJ, Farber MJ, Warycha MA, et al: The “dysplastic” nevus. Clin Dermatol 27:103–115, 2009.

Elder, DE: Dysplastic nevi: an update, Histopathology 56:112–120, 2010.